In AIS Health’s RADAR on Medicare Advantage publication, Faegre Drinker Consulting Principal Mike Adelberg discussed the release of the 2022 Medicare Advantage (MA) and Part D Rate Announcement on January 15 by the Centers for Medicare & Medicaid Services (CMS) and how it relates to the Biden administration.
In Part 2 of the Advance Notice, CMS floated the idea of two new star ratings measures, including one related to COVID-19 vaccinations, but it opted not to pursue them at this time, Adelberg noted. “CMS chose not to develop a star measure for provider directory accuracy — a longstanding difficulty. If you’re handicapping topics where the Biden administration might take a tougher position, this is a good one,” he added.
Meanwhile, the Trump administration’s late-term release of a final rulemaking policy and technical changes to the MA and Part D programs for Contract Year 2022 mostly involved “CMS codifying longstanding manual guidance,” observed Adelberg. “This will make it harder for the Biden administration to quickly change policies in regulation, and it [will] make it easier for the Biden administration to impose sanctions for clear violations of regulation.”
The full article is available for RADAR on Medicare Advantage subscribers.